Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 16Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 8Hodgkin Disease 8Burkitt Lymphoma 5Multiple Myeloma 4Lymphoma, T-Cell, Peripheral 4Lymphoma, Mantle-Cell 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia 3Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Primary Effusion 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Sezary Syndrome 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1

Interventions

Zidovudine 2Vincristine 2Valganciclovir 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tocilizumab 1tanespimycin 1liposomal doxorubicin 1ibrutinib 1deltacortene 1Sirolimus 1Polymerase Chain Reaction 1Methotrexate 1Interferon-alpha 1Hyaluronoglucosaminidase 1Histological Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × liposomal doxorubicin × Lymphoid × Clear all
NCT00092222 2026-06-01

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡